期刊文献+

氨溴索在哮喘性支气管炎治疗中的应用效果及安全性评价 被引量:4

Efficacy and Safety Evaluation of Ambroxol in the Treatment of Asthmatic Bronchitis
下载PDF
导出
摘要 目的探讨氨溴索在哮喘性支气管炎治疗中的应用效果及安全性。方法选取2016年1月~2017年1月在我院就诊的哮喘性支气管炎患者130例进行研究,按照患者入院时间奇偶数将患者分为两组,每组65例,对照组采用常规治疗,观察组采用氨溴索治疗,对两组治疗效果及FEV_1、FEV_1/FVC、不良反应情况进行对比。结果观察组患者总有效率为95.38%高于对照组为80.00%,差异有统计学意义(P<0.05);治疗后,观察组FEV_1(1.8±0.4)L、FEV_1/FVC(66.7±8.7)%,优于对照组(1.6±0.3)L、(56.9±6.3)%,差异有统计学意义(P<0.05)。结论采用氨溴索对哮喘性支气管炎患者进行治疗效果显著,有利于改善患者肺功能,且具有较高的安全性,可在临床上推广应用。 Objective To investigate the effect and safety of ambroxol in the treatment of asthmatic bronchitis.Methods From January 2016~2017 year in January in our hospital 130 cases of patients with asthmatic bronchitis were studied,according to the time of admission in patients with odd and even method,patients were divided into two groups,65 cases in each group,the control group received routine treatment,observation group were treated with ambroxol treatment,compared two groups of treatment and FEV1,FEV1/FVC,adverse reaction the situation.Results In the observation group,the total efficiency is 95.38%higher than that of control group was 80.00%,the difference was statistically significant(<0.05);after treatment,the observation group FEV1(1.8依0.4)L,FEV1/FVC(66.7依8.7)%,better than the control group(1.6依0.3)L,(56.9依6.3)%,with statistical significance the difference(<0.05).Conclusion Ambroxol is effective in the treatment of asthmatic bronchitis.It is beneficial to improve the lung function of patients,and has high safety.It can be widely applied in clinic.
作者 刘成丽 LIU Cheng-li(Department of Internal Medicine,Linghai Hospital of Traditional Chinese Medicine,Linghai 121200,Liaoning,China)
出处 《医学信息》 2018年第5期138-139,共2页 Journal of Medical Information
关键词 氨溴索 哮喘性支气管炎 肺功能 Ambroxol Asthmatic bronchitis Pulmonary function
  • 相关文献

二级参考文献51

  • 1王石磊,邢丽华.支气管哮喘诊断与治疗进展[J].中华哮喘杂志(电子版),2013,7(3):50-53. 被引量:19
  • 2侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:866
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 4王亚莉,方凤,陈国军,潘志尧,李步卓.喘可治雾化吸入辅助治疗儿童喘息性支气管炎疗效分析[J].上海中医药杂志,2007,41(2):43-44. 被引量:6
  • 5Slutsky AS,Imai Y,Ventilator-induced lung injury,cytokines,PEEPand mortality,implicaction for practice and for clinical trials(J).In-tensive Care Med,2003,29:1218-1221.
  • 6Sun B,Rider E,Ikegami M,et al.Antenatal ambroxol effects on sur-factant pool size and postnatal lung function in pretern ventilated rab-bits(J).Biol Neonate,1992,62:55-62.
  • 7Chu HY, Jain R, Xie H, et al. Voficonazole therapeutic drug monito- ring : retrospective cohort study of the relationship to clinical outcomes and adverse events[ J]. BMC Infect Dis,2013,13 : 105.
  • 8Guinea J, Torres-Narbona M, Gijon P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome [ J ]. Clin Mierobiol Infect, 2010, 16 ( 7 ) : 870- 877.
  • 9Metan G, Ko9 AN, Atalay A, et al. The peformance of galactomannan antigen assay in the diagnosis of invasive pulmonary aspergillosis at different cutoff values [ J ]. Mycoses,2011,54 ( Suppl 2 ) :80-81.
  • 10Metan G, Koc AN,Atalay A, et al. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary as- pergillosis in patients with haematological malignancies? [J]. Scand J Infect Dis,2012,44(5 ) :330-336.

共引文献51

同被引文献23

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部